» Articles » PMID: 35609599

Thermodynamic Analysis of Amyloid Fibril Structures Reveals a Common Framework for Stability in Amyloid Polymorphs

Overview
Journal Structure
Publisher Cell Press
Date 2022 May 24
PMID 35609599
Authors
Affiliations
Soon will be listed here.
Abstract

The increasing number of amyloid structures offers an opportunity to investigate the general principles determining amyloid stability and polymorphism. We find that amyloid stability is dominated by ∼30% of residues localized in segments that favor the cross-β conformation. These correspond to known aggregation-nucleating regions and constitute a stabilizing cross-β structural framework that is shared among polymorphs. Alternative packing of these segments with structurally frustrated regions within the protofilament results in conformationally different, but energetically similar, polymorphs. Differential analysis of distributions of interatomic distances in amyloid and globular structures revealed that unconventional residue contacts, such as identical charges in close proximity, are located in energetically frustrated segments of amyloids. These observations suggest that polymorphism results from a framework mechanism consisting of conserved stabilizing regions of high cross-β propensity. These are interspersed by structurally suboptimal regions that are potential sites of conformational plasticity and interaction with stabilizing cofactors such as (poly)ions.

Citing Articles

Functional classification of tauopathy strains reveals the role of protofilament core residues.

Vaquer-Alicea J, Manon V, Bommareddy V, Kunach P, Gupta A, Monistrol J Sci Adv. 2025; 11(4):eadp5978.

PMID: 39841851 PMC: 11753436. DOI: 10.1126/sciadv.adp5978.


The mechanism of amyloid fibril growth from Φ-value analysis.

Larsen J, Barclay A, Vettore N, Klausen L, Mangels L, Coden A Nat Chem. 2025; 17(3):403-411.

PMID: 39820805 DOI: 10.1038/s41557-024-01712-9.


Targeting Iron Responsive Elements (IREs) of APP mRNA into Novel Therapeutics to Control the Translation of Amyloid-β Precursor Protein in Alzheimer's Disease.

Khan M Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770511 PMC: 11677800. DOI: 10.3390/ph17121669.


Massively parallel genetic perturbation reveals the energetic architecture of an amyloid beta nucleation reaction.

Arutyunyan A, Seuma M, Faure A, Bolognesi B, Lehner B bioRxiv. 2024; .

PMID: 39091732 PMC: 11291115. DOI: 10.1101/2024.07.24.604935.


Molecular basis for non-invasive diagnostics of cardiac amyloids using bone tracers.

Lewkowicz E, Jayaraman S, Gursky O Biomater Sci. 2024; 12(17):4275-4282.

PMID: 39046441 PMC: 11334954. DOI: 10.1039/d4bm00816b.